Most recently, it has been discovered that conolidine and the above derivatives act within the atypical chemokine receptor 3 (ACKR3. Expressed in similar spots as classical opioid receptors, it binds into a big selection of endogenous opioids. Not like most opioid receptors, this receptor functions to be a scavenger https://lyndonp113dzt1.blogdal.com/profile